Y-mAbs Therapeutics Inc
NASDAQ:YMAB
Y-mAbs Therapeutics Inc
Total Other Income
Y-mAbs Therapeutics Inc
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Y-mAbs Therapeutics Inc
NASDAQ:YMAB
|
Total Other Income
$3.9m
|
CAGR 3-Years
50%
|
CAGR 5-Years
139%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
-$4.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-204%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$252m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$151m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
-$15.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
-$31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Y-mAbs Therapeutics Inc's Total Other Income?
Total Other Income
3.9m
USD
Based on the financial report for Dec 31, 2023, Y-mAbs Therapeutics Inc's Total Other Income amounts to 3.9m USD.
What is Y-mAbs Therapeutics Inc's Total Other Income growth rate?
Total Other Income CAGR 5Y
139%
The average annual Total Other Income growth rates for Y-mAbs Therapeutics Inc have been 50% over the past three years , 139% over the past five years .